Jerusalem, Israel

Mervyn Shapiro

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2002-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mervyn Shapiro: Innovator in Iontophoretic Drug Delivery

Introduction

Mervyn Shapiro is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of medical technology, particularly in drug delivery systems. With a total of 3 patents, his work focuses on enhancing the safety and efficacy of drug administration.

Latest Patents

One of Shapiro's latest patents is a safe device for iontophoretic delivery of drugs. This innovative device is designed to deliver a drug to or into a tissue while preventing operation at a current density that exceeds a predetermined value. The device includes a mechanism that responds to data indicative of the surface area through which the current is to pass, thereby setting the maximal current allowed. Additionally, the method for iontophoretically administering drugs involves determining a maximal allowed level of current density and ensuring that the application of current density does not exceed this level.

Career Highlights

Throughout his career, Mervyn Shapiro has worked with prominent organizations such as Hadasit Medical Research Services and Development Ltd. and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His experience in these institutions has allowed him to advance his research and development efforts in medical technologies.

Collaborations

Shapiro has collaborated with esteemed colleagues, including Abraham Domb and Joseph Frucht-Pery. These partnerships have contributed to the success of his innovative projects and have fostered advancements in the field of drug delivery systems.

Conclusion

Mervyn Shapiro's contributions to iontophoretic drug delivery highlight his commitment to improving medical technology. His innovative patents and collaborations reflect his dedication to enhancing patient care through safer drug administration methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…